目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Cancer Biomarkers Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Cancer Biomarkers Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Cancer Biomarkers Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cancer Biomarkers Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Breast Cancer
4.3.1. Breast Cancer Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Prostate Cancer
4.4.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Colorectal Cancer
4.5.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Cervical Cancer
4.6.1. Cervical Cancer Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Liver Cancer
4.7.1. Liver Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Lung Cancer
4.8.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cancer Biomarkers Market: Biomolecule Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Cancer Biomarkers Market: Biomolecule Movement Analysis, 2023 & 2030 (USD Million)
5.3. Genetic Biomarkers
5.3.1. Genetic Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Epigenetic Biomarkers
5.4.1. Epigenetic Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Metabolic Biomarkers
5.5.1. Metabolic Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Proteomic Biomarkers
5.6.1. Proteomic Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cancer Biomarkers Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cancer Biomarkers Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Drug Discovery and Development
6.3.1. Drug Discovery and Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostics
6.4.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cancer Biomarkers Market: Technology Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Cancer Biomarkers Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
7.3. Imaging Technology
7.3.1. Imaging Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. OMICS
7.4.1. OMICS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cancer Biomarkers Market: Regional Estimates & Trend Analysis
8.1. Cancer Biomarkers Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Thailand Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. South Korea Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Cancer Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. QIAGEN
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Affymetrix Inc
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Illumina, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Agilent Technologies
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. F. Hoffmann-La Roche AG
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Merck & Co. Inc
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Hologic, Inc
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Sino Biological Inc
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives